ASIAN FOOD INDUSTRIES AT P. O. DABH

Follow us on social media

We are a global leader in life science tools, partnering with customers to find solutions that diagnose, treat, feed and protect our growing population. Working collaboratively with our partners in the scientific community, our products and services help to solve some of the most complex challenges facing society and the planet.

Together we respond to global pandemics, pioneer innovative precision medicine, and improve the safety of our food, medicines and environment.

African elephant populations have stabilised in southern Africa after significant declines over the past century. This finding is based on the most comprehensive analysis of growth rates to date, showing that conservation efforts in these regions are helping to curb the population losses that were primarily driven by poaching and habitat destruction.

LGC supports these efforts with its KASP (Kompetitive Allele Specific PCR) technology, which enables precise genotyping of DNA from elephant samples, such as dung, providing critical data for conservation. KASP’s accuracy and versatility make it invaluable not only in wildlife research but also in agriculture and plant breeding, helping researchers identify genetic variations across a wide range of species.

A dangerous variant of the Mpox virus is spreading rapidly in parts of Central Africa, raising concerns about its potential to reach Europe. The World Health Organization (WHO) has declared it a “public health emergency of international concern” due to its fast transmission and severe impact, particularly on children. Vaccines and global cooperation are needed to contain the outbreak.

LGC’s AccuPlex Monkeypox Reference Material Kit contains positive reference materials aligned with the consensus sequences from the Centres for Disease Control (CDC) and World Health Organization (WHO). In cases where patient samples are too scarce or too hazardous to handle, AccuPlex technology provides the ideal solution for assay development and quality control, ensuring reliable diagnostics without direct exposure to high-risk materials.

Scientists are turning their attention to new types of “forever chemicals” which are far more widespread than previously understood. These synthetic substances are resistant to degradation, accumulating in the environment and living organisms. Used in the manufacturing of hundreds of everyday products, these chemicals have been linked to various health issues, including cancer and fertility problems. As awareness grows, companies have pledged to avoid these chemicals, and regulators are increasingly restricting their use.

Perfluoro alkylated substances (PFAS), a class of around 15,000 chemicals widely used for their water and oil-resistant properties, are known to persist in the environment due to their strong carbon-fluorine bonds. They contaminate air, soil and water and can also be found in food, beverages and packaging, leading to severe health risks, including cancer and liver damage. LGC Standards provides specialised reference materials for accurate PFAS testing, supporting compliance with regulations like the EU Drinking Water Directive and EPA Method 1633, safeguarding consumer health.

Microplastics, formed when plastics break down into particles smaller than 5 millimetres, may raise heart attack and stroke risk by accumulating in arterial plaques. These plastic-laden plaques restrict blood flow more than plastic-free ones, potentially contributing to cardiovascular disease, according to recent research on microplastics’ health effects.

Analysis of microplastics in food and the environment is challenging due to complexity of the surrounding matrices and the absence of harmonised measurement methods and reference materials. We are addressing these complex measurement challenges by developing reliable sample preparation strategies, representative test materials, and accurate measurement methods to ensure reliable and accurate results.

At just 4 months old, Leo Wei Church was diagnosed with an ultra-rare and severe neurodevelopmental disease involving a mutation in his Transportin-2 gene, which is critical to protein coding and normal intellectual development. Leo’s mutation caused significant and frequent seizures and interfered with his breathing. While Leo’s long-term prognosis remains uncertain, his progress is promising – and stands as a testament to the potential of rapid-development personalised therapeutics.

LGC Axolabs offers a unique services portfolio for the development of nucleic acid therapeutics and nucleic acid-based medicines. As a world-leading service provider in oligonucleotide- & mRNA-based therapeutics, we deliver the best solutions for nucleic acid therapeutics’ development, ranging from lead ID, across all clinical stages, to commercial supply. LGC Axolabs is dedicated to the highest scientific standards fostered by world class expertise and capabilities in oligonucleotide (bio)-analytics, clinical trial support, and cGMP manufacture.

Partnering with end-user labs, In Vitro Diagnostics (IVD) developers, biopharma, Contract Research Organisations (CROs), and academic institutions, we deliver comprehensive diagnostic solutions across the entire pipeline.

We provide end-to-end diagnostic solutions from design to commercialisation, specialising in infectious diseases, oncology, and prenatal testing. Our services are GMP, GLP, and ISO compliant, ensuring consistent quality and regulatory adherence.

Supporting industries like food and sports nutrition, our solutions ensure safety, quality, and transparency through globally recognised certifications, testing, and compliance software–including BRCGS, Informed, and Safefood360–we help businesses meet regulatory requirements.

LGC Standards is a global leader in research chemicals, analytical standards, and proficiency testing for a wide range of leading industries. Our trusted brands, including AXIO Proficiency Testing, Dr. Ehrenstorfer™, Mikromol™, and Toronto Research Chemicals (TRC), offer innovative products and a premier PFAS portfolio to meet the highest industry standards.

We specialise in the development, analysis and production of oligonucleotide- and mRNA-based therapeutics, offering comprehensive services from early discovery through to commercialisation, ensuring high-quality and efficient solutions.

We protect public health by ensuring the quality of food and medicines, supporting the UK government initiatives through the Government Chemist and National Measurement Laboratory in global measurement standardisation.

Joris Parmentier, Product Management Associate Director

Robyn Laskowski, Senior Manager, Lab Services

Wayne Gaunt, Head of Chemistry, Proficiency Testing

Saumu Lwembe, Assistant Director, Patient, Public Involvement and Engagement

Philipp Feuerriegel, Production Director EFF

Mahboubeh (Maria) Jokar, Synthetic Chemist Level 2

I am a molecular biologist by training and have been working in the biotechnology industry since I graduated in 2010, focusing on product development and strategic marketing. My expertise spans molecular biology, strategic marketing, start-ups, international sales, and product management.

I have always been passionate about translating science into practical applications for our customers. Over the years, I have built a robust network in genomics with a vision to impact the life-sciences industry through innovative business strategies. My goal is to contribute to the success of LGC by ensuring we offer the best portfolio in the world.

What do you most like about LGC?
The ‘get it done for the customer’ mentality and collaboration with great international colleagues.

Best advice for new members of the team?
Have fun! Don’t expect to sit back and relax, we’re a fast-growing company and you’re in for quite a ride so you might as well enjoy it!

I oversee the North America Lab Service groups that produce data (our ‘product’) for customers via the Flex-Seq and Capture-Seq NGS workflows, as well as assist with the Amp-Seq tGBS pilot program. Along with our colleagues in Berlin, we partner with diverse groups in the organization (Commercial, Product Management, and the Innovation Hub) to deliver data with speed, accuracy, and consistency.

Several of our customers utilize the data we generate to advance their breeding programs, whether it is plant or animal based. In part, this data contributes to decisions these organizations make that ultimately help secure food supply in dynamic environments.

What is something you value about working at LGC?

The diversity within LGC is phenomenal. I mean that in the broadest sense: global colleagues, customers, offerings from the organization, and exciting work opportunities vary within my day-to-day activities. I’ve learned so much since I joined the organization… and I can’t wait to learn more!

In my role, I oversee the production, testing, and assessment reports for all chemistry-related proficiency test materials offered by LGC. Proficiency testing is a crucial pillar for laboratories worldwide to ensure accurate testing. My responsibility is to identify areas where laboratories may be underperforming, allowing them to address issues promptly. This independent review is essential to guarantee the safety of the food we consume, the toys our children play with, and the air we breathe—things that most people take for granted.

What are you most proud of regarding your work at LGC?

I am most proud of the sheer diversity in the range of areas that LGC covers. This allows me the opportunity to be involved in a wide array of technical areas that most people never get to be part of, and it’s good knowing that we can make a difference in these areas.  One thing at LGC is that it’s never a dull day with new areas being introduced all the time.

I am an expert in the involvement of people and communities in health and care research. As an Assistant Director at the Grant Management Group, I have a key role in ensuring that diverse citizens can work in successful partnership with funders and with the funded research, both in the UK and in Low- and Middle-Income Countries (LMICs).

I undertake extensive engagements across NHS trusts, governments, multinational agencies, academia, civil society among others, both in the UK and LMICs, co-creating structures and redesigning solutions for effective public member involvement in research and service delivery, maximising research investment.

Best advice for new members of the team?
“LGC is a great organisation that provides opportunities for professional growth. Be proactive, speak to colleagues within and across teams – you’ll be happy you did.”

As the Production Director for the Environment, Food, and Forensics sector, I oversee the production of high-quality (certified) Reference Materials across various LGC sites. My collaboration within the LGC Group aims to elevate our product quality and significantly increase throughput. In my current role, I ensure that we maintain the same high-quality standards at all sites within the EFF sector.

Working at LGC Group offers numerous benefits, particularly due to the fantastic teams we have. Within the Group, you have access to contacts and resources whenever you need assistance. Leveraging the synergies within LGC has significantly enhanced our quality and throughput. We now have the capability to produce our products at multiple sites worldwide. This collaboration among colleagues from Europe, China, and the US exemplifies what I appreciate most about LGC.

Best advice for new members of the team?
Learn as much about the whole LGC Group as possible. LGC offers many chances, help and benefits that you may not see at first sight. Take your time to meet and talk to the people of the whole Group, get active in your science family, and become a part of the LGC family.

I am a synthetic chemist and the chemicals that are synthesized in TRC-LGC could be used in various aspects, such as: Analytical standards, APIs, bioactive molecules, natural products, impurity reference standards (IRS), metabolites, macrocycles, crucial drug discovery, measuring environmental contaminants, stable isotope labelled products that might be used by pharmaceutical companies to launch new drugs.